• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA BBS9 作为肺腺癌的早期诊断生物标志物:直接与 IFIT3 相互作用调节肿瘤免疫微环境。

Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment.

机构信息

Department of Pathology, Jinshan Branch of Shanghai Sixth People's Hospital, Shanghai, China.

Department of Automation, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Front Immunol. 2024 Jul 19;15:1344954. doi: 10.3389/fimmu.2024.1344954. eCollection 2024.

DOI:10.3389/fimmu.2024.1344954
PMID:39139574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320841/
Abstract

BACKGROUND

Introduction: Circular RNAs (circRNAs) have been identified as significant contributors to the development and advancement of cancer. The objective of this study was to examine the expression and clinical implications of circRNA circ_BBS9 in lung adenocarcinoma (LUAD), as well as its potential modes of action.

METHODS

The expression of Circ_BBS9 was examined in tissues and cell lines of LUAD through the utilization of microarray profiling, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot analysis. In this study, we assessed the impact of circ_BBS9 on the proliferation of LUAD cells, as well as its influence on ferroptosis and tumor formation. To analyze these effects, we employed CCK-8 assays and ferroptosis assays. The identification of proteins that interact with Circ_BBS9 was achieved through the utilization of RNA pull-down and mass spectrometry techniques. A putative regulatory network comprising circ_BBS9, miR-7150, and IFIT3 was established using bioinformatics study. The investigation also encompassed the examination of the correlation between the expression of IFIT3 and the invasion of immune cells.

RESULTS

Circ_BBS9 was significantly downregulated in LUAD tissues and cell lines. Low circ_BBS9 expression correlated with poor prognosis. Functional experiments showed that circ_BBS9 overexpression inhibited LUAD cell proliferation and promoted ferroptosis and suppressed tumor growth . Mechanistically, circ_BBS9 was found to directly interact with IFIT3 and regulate its expression by acting as a sponge for miR-7150. Additionally, IFIT3 expression correlated positively with immune infiltration in LUAD.

CONCLUSION

Circ_BBS9 has been identified as a tumor suppressor in lung adenocarcinoma (LUAD) and holds promise as a diagnostic biomarker. The potential mechanism of action involves the modulation of ferroptosis and the immunological microenvironment through direct interaction with IFIT3 and competitive binding to miR-7150. The aforementioned findings offer new perspectives on the pathophysiology of LUAD and highlight circ_BBS9 as a potentially valuable target for therapeutic interventions.

摘要

背景

介绍:环状 RNA(circRNAs)已被确定为癌症发生和发展的重要贡献者。本研究的目的是研究肺腺癌(LUAD)中 circRNA circ_BBS9 的表达及其临床意义,以及其潜在的作用方式。

方法

通过使用微阵列分析、定量实时聚合酶链反应(qRT-PCR)和 Western blot 分析,检测 LUAD 组织和细胞系中 circ_BBS9 的表达。在本研究中,我们评估了 circ_BBS9 对 LUAD 细胞增殖的影响,以及对铁死亡和肿瘤形成的影响。为了分析这些影响,我们采用了 CCK-8 测定和铁死亡测定。通过使用 RNA 下拉和质谱技术来鉴定与 Circ_BBS9 相互作用的蛋白质。通过生物信息学研究建立了包括 circ_BBS9、miR-7150 和 IFIT3 的假定调控网络。还检查了 IFIT3 表达与免疫细胞浸润之间的相关性。

结果

Circ_BBS9 在 LUAD 组织和细胞系中表达显著下调。低 circ_BBS9 表达与不良预后相关。功能实验表明,circ_BBS9 过表达抑制 LUAD 细胞增殖并促进铁死亡,抑制肿瘤生长。机制上,circ_BBS9 被发现可直接与 IFIT3 相互作用,并通过作为 miR-7150 的海绵来调节其表达。此外,IFIT3 的表达与 LUAD 中的免疫浸润呈正相关。

结论

Circ_BBS9 被鉴定为肺腺癌(LUAD)的肿瘤抑制因子,有望成为诊断生物标志物。潜在的作用机制涉及通过与 IFIT3 的直接相互作用和竞争性结合 miR-7150 来调节铁死亡和免疫微环境。上述发现为 LUAD 的病理生理学提供了新的视角,并强调 circ_BBS9 作为潜在有价值的治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/58d1d3d763f0/fimmu-15-1344954-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/acef7de4d29c/fimmu-15-1344954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/382ab5e359f8/fimmu-15-1344954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/79926e5e12d8/fimmu-15-1344954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/5186763f241a/fimmu-15-1344954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/e1cca6a7ca54/fimmu-15-1344954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/d5b930727d3d/fimmu-15-1344954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/df35393db7e4/fimmu-15-1344954-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/6d26f48d4292/fimmu-15-1344954-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/58d1d3d763f0/fimmu-15-1344954-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/acef7de4d29c/fimmu-15-1344954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/382ab5e359f8/fimmu-15-1344954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/79926e5e12d8/fimmu-15-1344954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/5186763f241a/fimmu-15-1344954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/e1cca6a7ca54/fimmu-15-1344954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/d5b930727d3d/fimmu-15-1344954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/df35393db7e4/fimmu-15-1344954-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/6d26f48d4292/fimmu-15-1344954-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18bb/11320841/58d1d3d763f0/fimmu-15-1344954-g009.jpg

相似文献

1
Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment.环状 RNA BBS9 作为肺腺癌的早期诊断生物标志物:直接与 IFIT3 相互作用调节肿瘤免疫微环境。
Front Immunol. 2024 Jul 19;15:1344954. doi: 10.3389/fimmu.2024.1344954. eCollection 2024.
2
A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.双环状 RNA 特征作为肺腺癌的非侵入性诊断生物标志物。
J Transl Med. 2019 Feb 18;17(1):50. doi: 10.1186/s12967-019-1800-z.
3
The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.新型环状 RNA circ-CAMK2A 通过调控 miR-615-5p/纤维连接蛋白 1 通路促进肺腺癌转移。
Cell Mol Biol Lett. 2019 Dec 26;24:72. doi: 10.1186/s11658-019-0198-1. eCollection 2019.
4
Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.环状 RNA circ-TSPAN4 通过海绵吸附 miR-665 而上调 ZEB1 促进肺腺癌转移。
Mol Genet Genomic Med. 2019 Dec;7(12):e991. doi: 10.1002/mgg3.991. Epub 2019 Oct 1.
5
Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.人源环状RNA hsa_circ_0070440通过溶质载体家族7成员11(SLC7A11)介导的铁死亡促进肺腺癌进展。
Histol Histopathol. 2023 Dec;38(12):1429-1441. doi: 10.14670/HH-18-597. Epub 2023 Feb 22.
6
Circular RNA Circ_0005962 Contributes to Lung Adenocarcinoma Cell Proliferation and Stem Cell Formation Through Sponging of miR-3611 and Modulating CYP24A1 Expression.环状 RNA Circ_0005962 通过海绵吸附 miR-3611 和调节 CYP24A1 表达促进肺腺癌细胞增殖和干细胞形成。
Biochem Genet. 2023 Aug;61(4):1242-1264. doi: 10.1007/s10528-022-10312-6. Epub 2022 Dec 21.
7
Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.环状RNA circCSNK1G3通过吸附hsa-miR-143-3p诱导HOXA10信号传导并促进肺腺癌细胞的生长和转移。
Cell Oncol (Dordr). 2021 Apr;44(2):297-310. doi: 10.1007/s13402-020-00565-x. Epub 2020 Oct 29.
8
Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p.环状核孔蛋白 98 通过 miR-188-3p 调控 CBX1 促进肺腺癌的发展。
Biochem Genet. 2024 Oct;62(5):3504-3522. doi: 10.1007/s10528-023-10609-0. Epub 2023 Dec 21.
9
CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.环状 RNA 抑制肺腺癌的进展通过调节 miR-6783-3p/DKK1 轴和失活 Wnt/β-连环蛋白信号通路。
Biochem Biophys Res Commun. 2019 Jan 1;508(1):37-45. doi: 10.1016/j.bbrc.2018.11.079. Epub 2018 Nov 20.
10
Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.Hsa_circ_0129047 通过调控 miR-375/ACVRL1 轴抑制肺腺癌的进展。
J Clin Lab Anal. 2022 Sep;36(9):e24591. doi: 10.1002/jcla.24591. Epub 2022 Jul 31.

引用本文的文献

1
Clinical Utility of IFIT Proteins in Human Malignancies.IFIT蛋白在人类恶性肿瘤中的临床应用
Biomedicines. 2025 Jun 11;13(6):1435. doi: 10.3390/biomedicines13061435.
2
Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies.解析非编码RNA在肿瘤微环境中的进展:癌症治疗的创新策略。
J Transl Med. 2025 Jun 2;23(1):614. doi: 10.1186/s12967-025-06629-6.
3
IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications.IFIT3:先天免疫和肿瘤进展中的关键介质及其治疗意义

本文引用的文献

1
LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis.长链非编码 RNA SLCO4A1-AS1 通过隔离 TOX4-NTSR1 信号轴抑制肺癌进展。
J Biomed Sci. 2023 Sep 19;30(1):80. doi: 10.1186/s12929-023-00973-9.
2
CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290/ACSL4 axis.CircSCN8A 通过调控 miR-1290/ACSL4 轴抑制非小细胞肺癌的恶性进展并诱导铁死亡。
Cell Cycle. 2023 Apr;22(7):758-776. doi: 10.1080/15384101.2022.2154543. Epub 2022 Dec 8.
3
The JAK-STAT pathway at 30: Much learned, much more to do.
Front Immunol. 2025 Feb 24;16:1515718. doi: 10.3389/fimmu.2025.1515718. eCollection 2025.
4
Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies.肺部疾病和肺癌中的铁死亡:分子机制、相互作用调节及治疗策略
MedComm (2020). 2025 Feb 23;6(3):e70116. doi: 10.1002/mco2.70116. eCollection 2025 Mar.
5
Exploration of telomere-related biomarkers for lung adenocarcinoma and targeted drug prediction.探索用于肺腺癌的端粒相关生物标志物及靶向药物预测。
Discov Oncol. 2025 Feb 10;16(1):148. doi: 10.1007/s12672-025-01847-2.
6
Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies.非编码 RNA 介导的铁死亡在泌尿系统恶性肿瘤中的关键作用。
Front Immunol. 2024 Oct 31;15:1486229. doi: 10.3389/fimmu.2024.1486229. eCollection 2024.
JAK-STAT 通路 30 年:学无止境,任重道远。
Cell. 2022 Oct 13;185(21):3857-3876. doi: 10.1016/j.cell.2022.09.023.
4
PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.PSMA5 与 JAK/STAT 通路一起促进肺腺癌的进展。
Carcinogenesis. 2022 Aug 30;43(7):624-634. doi: 10.1093/carcin/bgac046.
5
Mechanism of RNA circHIPK3 Involved in Resistance of Lung Cancer Cells to Gefitinib.环状 RNA circHIPK3 介导的肺癌细胞对吉非替尼耐药的机制研究。
Biomed Res Int. 2022 Apr 19;2022:4541918. doi: 10.1155/2022/4541918. eCollection 2022.
6
The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.环状 RNA circDLG1 通过海绵吸附 miR-141-3p 调控 CXCL12 促进胃癌进展和抗 PD-1 耐药。
Mol Cancer. 2021 Dec 15;20(1):166. doi: 10.1186/s12943-021-01475-8.
7
HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein.HNRNPL 环形化 ARHGAP35 以产生致癌蛋白。
Adv Sci (Weinh). 2021 May 1;8(13):2001701. doi: 10.1002/advs.202001701. eCollection 2021 Jul.
8
Inhibiting Ferroptosis through Disrupting the NCOA4-FTH1 Interaction: A New Mechanism of Action.通过破坏NCOA4-FTH1相互作用抑制铁死亡:一种新的作用机制
ACS Cent Sci. 2021 Jun 23;7(6):980-989. doi: 10.1021/acscentsci.0c01592. Epub 2021 May 6.
9
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer.肿瘤微环境亚型与乳腺癌预后的免疫相关特征。
Biomed Res Int. 2021 Jun 1;2021:6650107. doi: 10.1155/2021/6650107. eCollection 2021.
10
Differentiation and Regulation of T Cells: A Balancing Act for Cancer Immunotherapy.T 细胞的分化和调控:癌症免疫治疗的平衡之举。
Front Immunol. 2021 May 3;12:669474. doi: 10.3389/fimmu.2021.669474. eCollection 2021.